RSC Advances
Paper
for 2 h. Subsequently, 2-isopropoxy-4,4,5,5-tetramethyl-[1,3,2]- CDCl3): 154.4, 152.0, 151.3, 141.4, 141.3, 141.2, 140.4, 139.1,
dioxaborolane (1.15 mL, 5.64 mmol) was added rapidly to the 135.9, 133.5, 132.6, 128.2, 127.8, 126.2, 125.7, 125.2, 123.8,
solution, and the resulting mixture was warmed to room 123.3, 122.9, 121.6, 120.4, 120.2, 119.6, 118.7, 109.2, 109.1, 55.3,
temperature and stirred overnight. The reaction mixture was 47.5, 40.3, 39.5, 31.0, 28.9, 26.2, 24.4, 23.2, 23.0, 14.1, 13.9, 10.9.
poured into water and extracted with chloroform. The organic MS (Maldi-TOF): (m/z) calcd: 1242.75; found: 1242.43.
extracts were washed with brine and dried with anhydrous
sodium sulphate. The solvent was removed by rotary evapora- 4,7-Bis(9,9-dibutyl-7-(11-(2-ethylhexyl)-11H-benzo[a]carbazol-
tion and puried by column chromatography over silica gel with 8-yl)-9H-uoren-2-yl) benzo[c][1,2,5]thiadiazole (BFBFB)
n-hexane : ethyl acetate (95 : 5) as the eluent to give the desired
This compound was synthesized according to a procedure
similar to that of 10, using 8-(9,9-dibutyl-7-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)-9H-uoren-2-yl)-11-(2-ethyl hexyl)-11H-
product as a white solid (2.9 g, 4.25 mmol, 90% yield). 1H NMR
(500 MHz, CDCl3): 8.59–8.55 (d, 2H, J ¼ 10.6 Hz), 8.37–8.34 (d,
1H, J ¼ 8.3 Hz), 7.66–7.61 (m, 3H), 4.61 (m, 2H, N–CH2), 2.36–
benzo[a]carbazole (9b; 1.04 g, 1.43 mmol) and 2,7-dibromo
2.27 (m, 5H), 1.53 (s, 12H), 1.46–1.25 (m, 12H), 0.96–0.83 (m,
benzothiadiazole (2) to give the desired product 11 as a yellow
16H). 13C NMR (125 MHz, CDCl3): 151.6, 149.7, 143.8, 141.3,
solid. (600 mg, 0.45 mmol, 62% yield). 1H NMR (500 MHz,
140.9, 139.9, 134.4, 133.6, 132.2, 128.5, 127.3, 126.8, 125.8,
CDCl3): 8.51–8.46 (dd, 4H, J ¼ 22.9 Hz), 8.26–8.25 (d, 2H, J ¼ 5.3
125.4, 124.9, 123.0, 122.6, 121.1, 120.2, 120.0, 118.6, 118.3,
Hz), 8.05–8.01 (m, 5H), 7.88–7.80 (m, 5H), 7.78–7.76 (m, 3H),
108.8, 108.7, 83.2, 54.8, 46.9, 40.0, 39.0, 30.6, 28.5, 26.6, 25.7,
7.67–7.66 (d, 2H, J ¼ 6.4 Hz), 7.57–7.55 (d, 2H, J ¼ 6.3 Hz), 7.52–
24.6, 24.0, 22.8, 22.7, 13.8, 13.6, 10.6. ESI-MS: m/z 683 [M]+.
7.51 (d, 4H, J ¼ 8.3 Hz), 7.51–7.50 (m, 2H), 7.15 (s, 1H), 4.6–4.56
(m, 2H, N–CH2), 2.30–2.18 (m, 10H), 1.46–1.38 (m, 24H) 1.29–
1.18 (m, 19H) 0.86–0.76 (m, 12H). 13C NMR (125 MHz, CDCl3):
8-(9,9-Dibutyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
9H-uoren-2-yl)-11-(2-ethylhexyl)-11H-benzo[a]carbazole (9b)
154.4, 152.0, 151.3, 141.3, 141.2, 140.7, 139.2, 135.9, 135.1,
133.7, 133.5, 129.6, 128.9, 128.2, 127.8, 126.3, 125.1, 124.5,
124.3, 123.9, 123.3, 122.5, 121.7, 120.7, 120.3, 119.6, 119.2,
117.8, 110.1, 55.3, 50.1, 40.3, 39.7, 30.6, 28.5, 26.2, 23.8, 23.2,
23.0, 14.0, 13.9, 10.8. MS (Maldi-TOF): (m/z) calcd: 1342.78;
found: 1342.43.
This compound was synthesized according to the procedure
similar to that of 9a, using 8-(7-bromo-9,9-dibutyl-9H-uoren-2-
yl)-11-(2-ethylhexyl)-11H-benzo[a]carbazole (3.0 g, 4.38 mmol) to
give the desired product as a white foamy solid. (2.8 g, 3.82 mmol,
87% yield). 1H NMR (500 MHz, CDCl3): 8.42–8.38 (d, 2H, J ¼ 10.6
Hz), 8.18–8.17 (d, 1H, J ¼ 8.3 Hz), 7.97–7.62 (m, 10H), 7.59–7.44
(m, 3H), 4.44–4.41 (m, 2H, N–CH2), 2.12–2.09 (m, 5H), 1.36 (s,
12H), 1.29–1.08 (m, 12H), 0.82–0.79 (t, 6H), 0.70–0.66 (m, 10H).
13C NMR (125 MHz, CDCl3): 151.7, 149.8, 143.8, 141.3, 140.3,
139.1, 134.7, 133.6, 133.4, 132.8, 129.3, 128.6, 126.8, 125.9, 124.7,
124.2, 123.9, 122.9, 122.2, 121.9, 121.3, 120.4, 120.2, 119.3, 118.8,
118.7, 117.5, 109.8, 83.4, 54.9, 49.6, 40.1, 39.3, 30.3, 28.2, 25.7,
24.7, 23.6, 22.9, 22.7, 13.8, 13.6, 10.5. MS (EI): m/z 731 [M]+.
4,7-Bis (5-(9-(2-ethylhexyl)-9H-carbazol-3-yl) thiophen-2-yl)
benzo[c][1,2,5]thiadiazole (CTBTC)
A mixture of 9-(2-ethylhexyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxa-
borolan-2-yl)-9H-carbazole (7a; 0.93 g, 2.3 mmol) and 4,7-bis(5-
bromothiophen-2-yl)benzo[c][1,2,5]thiadiazole (4; 500 mg, 1.1
mmol) was dissolved in a mixture of toluene and aqueous 2 M
potassium carbonate solution (3 : 1, v/v). Subsequently, tetra-
kis(triphenylphosphine)palladium (63 mg, 0.005 mmol) and 18
mol% of 18-crown-6 were added to the solution, followed by
degassing with nitrogen for 15 min. The reaction mixture was
heated to 80 ꢁC under nitrogen atmosphere for 24 h. The cooled
crude mixture was poured into water, extracted with chloro-
form, dried over anhydrous sodium sulphate and evaporated to
yield crude product. The residue was puried by column chro-
matography using n-hexane as the eluent to give the desired
product 12 as a black solid (587 mg, 0.69 mmol, 52% yield). 1H
NMR (500 MHz, CDCl3): 8.26 (m, 2H), 8.09–8.08 (d, 2H, J ¼ 7.2
Hz), 7.92 (m, 2H), 7.65–7.54 (m, 6H), 7.4–7.2 (m, 8H), 3.98 (m,
4H, N–CH2), 1.98 (m, 2H), 1.50–1.23 (m, 16H), 0.86–0.83 (m,
12H). 13C NMR (125 MHz, CDCl3): 152.2, 146.6, 141.1, 137.1,
128.3, 125.7, 125.1, 124.9, 124.6, 123.6, 122.9, 122.5, 122.4,
120.2, 118.8, 117.3, 117.2, 109.0, 108.9, 47.2, 30.7, 28.5, 24.1,
22.3, 13.9, 13.8, 10.7. MS (Maldi-TOF): (m/z) calcd: 854.38;
found: 854.
4,7-Bis(9,9-dibutyl-7-(9-(2-ethylhexyl)-9H-carbazol-3-yl)-9H-
uoren-2-yl)benzo[c][1,2,5] thiadiazole (CFBFC)
3-(9,9-Dibutyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
9H-uoren-2-yl)-9-(2-ethylhexyl)-9H-carbazole (9a; 0.98 g, 1.43
mmol) and 4,7-dibromobenzo[c][1,2,5]thiadiazole (200 mg, 0.7
mmol) were dissolved in a mixture of toluene and aqueous 2 M
potassium carbonate solution (3 : 1, v/v). Subsequently, tetra-
kis(triphenylphosphine)palladium (48 mg, 0.005 mmol) and 10
mol% of 18-crown-6 were added to the solution followed by
degassing with nitrogen for 15 min. The reaction mixture was
heated at 80 ꢁC under nitrogen atmosphere for 24 h. The cooled
reaction mixture was ltered, poured into water, extracted with
chloroform, dried over anhydrous sodium sulphate and evap-
orated to yield the crude product. The residue was puried by
column chromatography using n-hexane as the eluent to give
the desired product 10 as a yellow solid (658 mg, 0.53 mmol,
1
74% yield). H NMR (500 MHz, CDCl3): 8.42 (s, 2H), 8.22–8.20
4,7-Bis(5-(11-(2-ethylhexyl)-11H-benzo[a]carbazol-8-yl)
thiophen-2-yl)benzo[c][1,2,5] thiadiazole (BTBTB)
(d, 2H, J ¼ 7.7 Hz), 8.11–8.07 (d, 2H, J ¼ 7.9 Hz), 7.99 (s, 2H),
7.93–7.74 (m, 8H), 7.52–7.44 (m, 3H), 7.41–7.29 (m, 6H), 7.27–
7.24 (m, 3H), 4.22–4.20 (m, 2H, N–CH2), 2.16–2.12 (m, 10H), This compound was synthesized according to a procedure
1.54–4.38 (m, 20H), 0.89–0.76 (m, 12H). 13C NMR (125 MHz, similar to that of 12, using 11-(2-ethylhexyl)-8-(4,4,5,5-
35322 | RSC Adv., 2014, 4, 35318–35331
This journal is © The Royal Society of Chemistry 2014